[go: up one dir, main page]

SE9002684D0 - New peptides and their use - Google Patents

New peptides and their use

Info

Publication number
SE9002684D0
SE9002684D0 SE9002684A SE9002684A SE9002684D0 SE 9002684 D0 SE9002684 D0 SE 9002684D0 SE 9002684 A SE9002684 A SE 9002684A SE 9002684 A SE9002684 A SE 9002684A SE 9002684 D0 SE9002684 D0 SE 9002684D0
Authority
SE
Sweden
Prior art keywords
amino acid
glu
pct
acid residue
residue selected
Prior art date
Application number
SE9002684A
Other languages
English (en)
Inventor
N Ahlborg
Original Assignee
Malvac Foundation C O Peter Pe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Malvac Foundation C O Peter Pe filed Critical Malvac Foundation C O Peter Pe
Priority to SE9002684A priority Critical patent/SE9002684D0/sv
Publication of SE9002684D0 publication Critical patent/SE9002684D0/sv
Priority to DE69127974T priority patent/DE69127974T2/de
Priority to AT91915658T priority patent/ATE159172T1/de
Priority to PCT/SE1991/000541 priority patent/WO1992003159A1/en
Priority to EP91915658A priority patent/EP0544781B1/en
Priority to AU83985/91A priority patent/AU656914B2/en
Priority to US07/969,305 priority patent/US5609872A/en
Priority to CA002089660A priority patent/CA2089660A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE9002684A 1990-08-17 1990-08-17 New peptides and their use SE9002684D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9002684A SE9002684D0 (sv) 1990-08-17 1990-08-17 New peptides and their use
DE69127974T DE69127974T2 (de) 1990-08-17 1991-08-16 Peptide und deren verwendung
AT91915658T ATE159172T1 (de) 1990-08-17 1991-08-16 Peptide und deren verwendung
PCT/SE1991/000541 WO1992003159A1 (en) 1990-08-17 1991-08-16 New peptides and their use
EP91915658A EP0544781B1 (en) 1990-08-17 1991-08-16 New peptides and their use
AU83985/91A AU656914B2 (en) 1990-08-17 1991-08-16 New peptides and their use
US07/969,305 US5609872A (en) 1990-08-17 1991-08-16 Peptides comprising a protective epitope from blood stages of plasmodium falciparum
CA002089660A CA2089660A1 (en) 1990-08-17 1991-08-16 New peptides and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002684A SE9002684D0 (sv) 1990-08-17 1990-08-17 New peptides and their use

Publications (1)

Publication Number Publication Date
SE9002684D0 true SE9002684D0 (sv) 1990-08-17

Family

ID=20380175

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9002684A SE9002684D0 (sv) 1990-08-17 1990-08-17 New peptides and their use

Country Status (8)

Country Link
US (1) US5609872A (sv)
EP (1) EP0544781B1 (sv)
AT (1) ATE159172T1 (sv)
AU (1) AU656914B2 (sv)
CA (1) CA2089660A1 (sv)
DE (1) DE69127974T2 (sv)
SE (1) SE9002684D0 (sv)
WO (1) WO1992003159A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828416B1 (en) 1998-08-21 2004-12-07 The United States Of America As Represented By The Department Of Health And Human Services Recombinant multivalent malarial vaccine against Plasmodium falciparum
FR2822834B1 (fr) * 2001-04-02 2005-02-25 Flamel Tech Sa Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
JP4732696B2 (ja) 2002-04-09 2011-07-27 フラメル・テクノロジー 活性成分の改変された放出のための、マイクロカプセルの水性懸濁液形態での経口医薬品製剤
AU2003246791A1 (en) * 2002-04-09 2003-10-20 Flamel Technologies Oral suspension of amoxicillin capsules
FR2840614B1 (fr) 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
FR2843117B1 (fr) * 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
FR2855521B1 (fr) * 2003-05-28 2005-08-05 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
FR2860516B1 (fr) * 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000597A1 (en) * 1986-07-17 1988-01-28 Saramane Pty. Ltd.; Small molecular weight antigen of plasmodium falciparum
US4957738A (en) * 1987-01-14 1990-09-18 Patarroyo Manuel E Protein copolymer malaria vaccine

Also Published As

Publication number Publication date
EP0544781A1 (en) 1993-06-09
AU8398591A (en) 1992-03-17
WO1992003159A1 (en) 1992-03-05
US5609872A (en) 1997-03-11
ATE159172T1 (de) 1997-11-15
DE69127974T2 (de) 1998-02-12
CA2089660A1 (en) 1992-02-18
AU656914B2 (en) 1995-02-23
EP0544781B1 (en) 1997-10-15
DE69127974D1 (de) 1997-11-20

Similar Documents

Publication Publication Date Title
MX9304089A (es) Uso de gm-csf como una vacuna adyuvante.
ES2100240T3 (es) Bacteriofagos modificados mediante ingenieria genetica y vacunas que los contienen.
PT82975A (en) Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein and of vaccine against the malaria
SE9002684D0 (sv) New peptides and their use
ATE153071T1 (de) Neue proteinhaltige partikeln
CA2169297A1 (en) Protein- or peptide-cochleate vaccines and methods of immunizing using the same
ATE169638T1 (de) Analoge des menschlichen interleukin-8.
GB9219936D0 (en) Vaccines
NZ243167A (en) Protein with one or more immunogenic determinants of an eimeria antigen and its production and use
SE9101838D0 (sv) Novel peptides and their use
DK0491628T3 (da) Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner
MX9300787A (es) Peptido para diagnosticar e inmunizar contra la infeccion por t. cruzi.
DK0425082T3 (da) Vacciner
PT787796E (pt) Epitopos protectores de ciclase do adenilo-hemolisina (ac-hly), sua aplicação ao tratamento ou à prevenção das infecções por bordetella
EA200301125A1 (ru) Вакцины, включающие в качестве адъюванта интерферон типа i, и связанные с этим способы
ATE115861T1 (de) Verwendung von adenylzyclase als vakzin gegen bordetella.
ATE136586T1 (de) Protektive plasmodium falciparum hybridproteine, die teilsequenzen der malaria-antigene hrpii und serp enthalten
EP0293333A3 (en) A synthetic nonapeptide of use as an adjuvant
DK204588D0 (da) Humane rhinoviruspeptider, fremgangsmaade til deres fremstilling samt vacciner med inhold af saadanne peptider
WO1994004565A3 (en) Ipnv vaccine
IL91609A0 (en) Allelic variants of plasmodium falciparum merozoite surface antigen
EP0392095A3 (en) Tuftsin analogues and vaccines containing these as adjuvants
IT8821666A0 (it) Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
GB9910375D0 (en) Vaccine composition